Anders Vahlne
Corporate Officer/Principal at Karolinska Institutet
Profile
Dr. Anders Vahlne is Chief Executive Officer, Director & Head-Research at Chrontech Pharma AB, a Professor at Karolinska Institutet, and a Member at University College Dublin.
He is on the Board of Directors at Chrontech Pharma AB.
Dr. Vahlne was previously employed as Head-Research by Tripep AB.
Anders Vahlne active positions
| Companies | Position | Start |
|---|---|---|
| Karolinska Institutet | Corporate Officer/Principal | 2010-10-31 |
| University College Dublin | Corporate Officer/Principal | 2010-10-31 |
Former positions of Anders Vahlne
| Companies | Position | End |
|---|---|---|
Fastilium Property Group AB
 Fastilium Property Group AB Real Estate DevelopmentFinance Fastilium Property Group AB engages in the development and management of residential and commercial properties. The company was founded on June 7, 2006, and is headquartered in Stockholm, Sweden. | Chief Executive Officer | 2014-12-16 |
Din Bostad Sverige AB
 Din Bostad Sverige AB Real Estate DevelopmentFinance Din Bostad Sverige AB operates a residential property business. The company is headquartered in Huddinge, Sweden. | Chief Tech/Sci/R&D Officer | 2005-12-31 |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 2 |
|---|---|
Fastilium Property Group AB
Fastilium Property Group AB Real Estate DevelopmentFinance Fastilium Property Group AB engages in the development and management of residential and commercial properties. The company was founded on June 7, 2006, and is headquartered in Stockholm, Sweden. | Finance |
Din Bostad Sverige AB
Din Bostad Sverige AB Real Estate DevelopmentFinance Din Bostad Sverige AB operates a residential property business. The company is headquartered in Huddinge, Sweden. | Finance |
- Stock Market
- Insiders
- Anders Vahlne
